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Abstract The great incidence of cardiovascular (CV)
diseases in the world spurs the search for new solutions to
enable an early detection of pathological processes and
provides more precise diagnosis based in multi-parameters
assessment. The pulse wave velocity (PWV) is considered
one of the most important clinical parameters for evaluate
the CV risk, vascular adaptation, and therapeutic efficacy.
Several studies were dedicated to find the relationship
between PWV measurement and pathological status in
different diseases, and proved the relevance of this
parameter. The commercial devices dedicate to PWV
estimation make a regional assessment (measured between
two vessels), however a local measurement is more precise
evaluation of artery condition, taking into account the
differences in the structure of arteries. Moreover, the cur-
rent devices present some limitations due to the contact
nature. Emerging trends in CV monitoring are moving
away from more invasive technologies to non-invasive and
non-contact solutions. The great challenge is to explore the
new instrumental solutions that allow the PWV assessment
with fewer approximations for an accurately evaluation and
relatively inexpensive techniques in order to be used in the
clinical routine.
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1 Introduction
Cardiovascular diseases (CVDs) are a group of disorders that
includes several heart diseases of circulatory system [1]. The
World Health Organization refers the CVDs as the world-
wide leading cause of death, resulting in a number of annu-
ally deceased people higher than from any other cause [1].
The improvements of diagnostics, treatments, medications,
and surgical techniques were responsible for a significant
decrease in total CVD mortality over the past few decades [1,
2]. Nonetheless, it is estimated that 17 million people died
from CVD in 2011, which represents approximately 30 % of
the global deaths, and approximately 23 million by 2030, to
remain the single leading cause of death [3].
The great incidence of CVDs in the world spurred the
search for new solutions to enable an early detection of
pathological processes, to monitor the vital signals con-
tinuously, and to provide a more precise diagnosis based in
multi-parameters assessment [4]. An accurate assessment
of the CV system changes and the identification of risk
factors is of utmost importance to avoid hospitalization and
to reduce CVD morbidity and mortality rates [5]. The early
detection based in multi-parameters of pathological con-
dition is the key to the patient survival. Current CV risk
evaluation systems are based on clinical judgment and
traditional vital signals measurement, including heart rate,
respiratory rate, blood pressure (BP), temperature and pulse
oximetry. However, these vital signals are not sufficient to
predict and evaluate the CVDs risk [1]. The appropriate
management of classical risk factors such as (age, gender,
smoking habits, hypertension, body mass index) and bio-
logical analysis (cholesterol, glucose, triglycerides, potas-
sium, sodium) together with new biomarkers [pulse wave
velocity (PWV), augmentation index] may represent a
better method for more accurate diagnosis [6, 7].
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Biomarkers are characteristics that are measured and
evaluated as indicators of normal stages or pathogenic
processes and responses to therapeutic interventions [8].
Efforts to identified new biomarkers have largely focused
on the use of new measurements [9]. PWV is an emerging
biomarker useful for CV risk stratification of patients,
assessment of BP [10], vascular stiffness and for thera-
peutic effects and efficacy in clinical studies [11–13].
The arterial stiffness is the first vessels modification,
responsible for several pathological processes, which can
lead to CVDs. For this reason, the arterial elastic properties
are used for risk stratification purposes in several popula-
tions. Recently, the European Society of Cardiology
guidelines for the management of arterial hypertension
suggested the measurement of PWV, considered the gold
standard method for assessing arterial stiffness, as a tool to
evaluate the arterial system damage, vascular adaptation,
and therapeutic efficacy [6].
Another important application of PWV measurement is
the indirect estimation of BP. It has been demonstrated that
PWV is inversely related with BP and have been reported
to be suitable for indirect BP measurements [14]. Important
part of research studies in PWV was focused in the cor-
relation between PWV and BP and on the development of a
cuff-less continuous BP monitoring device [15–17]. Sev-
eral models were proposed for BP estimation based in the
PWV measurement [18], and they were based in the arte-
rial wall mechanics and wave propagation in the arteries
[18–20]. However, major progress on the algorithms to
determine the BP using the PWV measurement is still
required, like the calibration of pulse transit time (PTT, in
units of ms) to BP (in units of mmHg) [21].
Apart from invasive methods, the PWV can also be
measured using non-invasive, reproducible and relatively
inexpensive techniques [7]. Many different waves have
been used to determine the PWV, such as pressure wave,
distension wave or flow wave. Commercial devices dedi-
cate to PWV measurements make a regional assessment,
i.e., the PWV is measured between two vessels. However
the advantages of a local measurement are evident and
some solutions are being exploited that enable this mea-
surement in a short vessel segment.
There is an ever-increasing need and demand for novel and
more efficient diagnostic tools to early detect CVDs. The great
challenge is to explore new sensors and configurations that
allow the PWV assessment with fewer approximations, leading
to an accurate evaluation, and to develop relatively inexpensive
techniques in order to be considered an interesting clinical
solution. This paper aims to review the most relevant studies on
PWV and introduce the discussion of advantages, disadvan-
tages and applications of biomedical instrumentation for local
versus regional PWV measurements.
2 Pulse Wave Velocity: Regional Versus Local
PWV is defined as the velocity at which the pressure
waves, generated by the systolic contraction of the heart,
propagate along the arterial tree. The evaluation of PWV
provides complementary information about the elastic
properties of arterial system. The higher PWV corresponds
to lower vessel distensibility and compliance and, there-
fore, to higher arterial stiffness. As the mechanical prop-
erties of the arterial walls change along the arterial system,
from the large arteries to the periphery, PWV is also
affected by these changes. The pulse waves travels through
the arteries and its velocity depends of the vessel. PWV
increases with the distance from the heart, along with the
elastic condition of the arterial wall, which is affected by a
variety of factors in the pathological process [22].
The regional PWV assessment is usually done in two
different arteries (commonly the carotid and femoral arter-
ies). Typical sites for pulse assessment are those where the
pulsation can be easily felt, such as in the radial artery, in the
common carotid artery, in the brachial or femoral arteries.
The regional PWV only provides the average PWV over a
long segment composed of arteries with different mechanical
characteristics [22], consequently, regional measurements of
PWV may mask the initial variations in arterial properties
and could not evaluate biomechanical properties in a small
segment and give no information about the position of the
arterial abnormalities [23]. In the early stage of arterial
stiffness, fibrous spots with small diameter are scattered on
the arterial wall and, in the final stage, the arterial wall
becomes homogeneously hard. The local PWV measure-
ment is made on a short segment of an artery and represents
an early diagnosis tool able to identify the local stiffness of
the arterial wall [24, 25].
On the other hand, the regional estimation is based an
external measurement of distance between the site where
the pulse waveform was acquired. This coarse approxi-
mation of the distance between test points constituting an
important disadvantage in the PWV assessment. The cur-
vatures within the vasculature limit this approach, the
problem of the distance measurement could be more severe
in the presence of tortuous vessels that is not considered in
an external measurement [26].
Carotid–femoral PWV is accepted as the ‘gold-standard’
measurement of arterial stiffness and it has been used to
predict the CV events, assess the hypertensive, diabetics,
and evaluate patients with chronic renal failure and coro-
nary heart disease [6, 27]. The local PWV measurement is
clinically important in local analyses of arterial wall
properties to providing diagnostic information of biome-
chanical properties for local artery wall [23]. The
mechanical characteristics of arterial vessels vary along the
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arterial tree and are differently affected by aging and dis-
ease [28]. On clinical application, in the early stage of
atherosclerosis disease, the elastic properties will be
affected locally and thus the functional properties of the
local large arteries can be analysed with local assessment
of PWV [28]. Recently studies have been dedicated to the
local PWV measurement expecting to find diagnostic
biomechanical information in some pathophysiologic con-
ditions [28, 29].
The current methods dedicated to the pulse velocity
estimation are based electromechanical solutions and all of
them establish direct contact with the patient’s tissues at
the artery site, which may distort the waveform. For
instance, the probe needs to be placed over the widest
pulsation area, and requires support from solid structures
such as the bone. Several patients also feel quite a dis-
comfort during the measurements, especially when their
pulsation is not easily assessed (i.e., obese patients) [30].
The new solutions that are being developed try to over-
come practical and technical limitations inherent to the
currently used methods.
2.1 Regional Pulse Wave Velocity
Framingham study created a multivariate risk scores to
help the risk level of CVD classification. The first Fram-
ingham risk score was calculated by using information of
disease, age, gender, diabetes, smoking, BP, and blood
lipid concentrations. Several studies followed the Fram-
ingham work in order to improve and develop new
guidelines for CVD risk management based on many others
parameters that could amend the assessing individual risk.
The multiple parameter risk response score is a useful tool
to categorize patients in order to select the appropriate
therapeutics. In the following studies main focus was given
to the regional PWV as a predictive factor of CVD [31].
Woolam et al. estimated the PWV, using a piezoelectric
crystal microphone to record the pressure pulse in radial
and carotid arteries, in healthy subjects as ranged between
6.75 and 9.04 m s-1 and for diabetic subjects varying from
8.35 to 12.76 m s-1. A significant increase in the PWV
was found in the diabetic subjects [32].
Isnard et al. studied, in a small population, the differ-
ences of PWV in normal subjects (8.9 ± 0.3 m s-1) and
hypertension patients (11.8 ± 0.5 m s-1) [33].
Asmar et al. studied the PWV in 418 subjects and
concluded that age and systolic pressure are the major
determinants for the velocity of pulse propagation [34].
The differences between the PWV in normotensive,
untreated hypertensive and treated subjects were studied.
This study concluded that the age as a most important
factor contributing to increase PWV, but did not suggest an
important role of antihypertensive drug [35].
Blacher et al. developed a study in a hypertensive
population, that showed the correlation of PWV with
atherosclerosis alterations and constitutes a predictor of CV
risk in hypertensive patients [36].
The relationship of PWV and CVDs was investigated in
a hypertensive patients, and was verified higher PWV in
patients with clinical vascular disease [37].
PWV was studied in subjects with 70–100 years old,
which indicate that the increase in aortic PWV is an
independent marker of CV risk in subjects with more than
70 years of age [38].
Laurent et al. performed a 9.3 years follow up study
with 1980 patients, with the aim of determining if PWV is
an independent predictor of CV mortality in hypertensive
patients. The authors related that an increasing in 5 m s-1
in PWV is equivalent to an aging of 10 years in terms of
increasing the mortality risk [39].
A study with a cohort of 1045 hypertensive patients with
a mean age of 51 years and with a mean follow up period
of 5.7 years, shows that relative risk of coronary event or
any CV event increased with the increasing of PWV and
evidences that PWV is an independent predictor of primary
coronary events in patients with hypertension [40].
Another study, with random sample of 1678 subjects
aged from 40 to 70 years, show similar values for PWV
independently of gender, 10.8 ± 3.2 m s-1 for females
and 11.8 ± 3.6 m s-1 for males. The authors refer the need
to develop more sensitive techniques to measure the stiff-
ness of various compartments of the arterial tree, which can
be readily applied in routine clinical practice for risk
stratification [41].
In the reference values for arterial stiffness collabora-
tion, an European cross-sectional study, performed in
11,902 subjects, where PWV was assessed regionally
(carotid–femoral) using several devices, it was showed that
the obtained PWV values were lower in the group classi-
fied as normotensive (without CV risk factors subjects),
from which the authors had established normal values of
PWV. The results also demonstrated that PWV increases
with age and hypertension severity. The normotensive
group had a PWV mean distribution between
6.6 ± 0.8 m s-1 for subjects under 30 years old, and
11.7 ± 2.9 m s-1 for the age category above 70 years old
[42].
A multicenter, observational study included 2200 Por-
tuguese subjects, underwent clinical assessment and annual
PWV measurement, demonstrated that PWV was signifi-
cantly higher in individuals with CV events (11.76 ±
2.13 m s-1) than in those without events (10.01 ± 2.01
m s-1), evidencing the clinical relevance of PWV as a CV
risk marker [43].
Several studies have been focused on the determination
of reference PWV values in groups with healthy subjects
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and patients with CVDs, hypertension, diabetes or heart
disease. Although most of these studies have been per-
formed for regional PWV, the local measurement of the
PWV is pertinent because of the arteriosclerosis local
nature.
Table 1 gives a global vision of the results obtained in
the multiple studies.
2.2 Local Pulse Wave Velocity
Peripheral arteries are significantly stiffer than central
arteries and this fact skews the interpretation of the real
values of PWV. Besides that, the PWV in large central
elastic arteries, such as the aorta or carotid, increases with
age, whereas brachial or femoral arteries PWV do not
increase so markedly [44]. Therefore, the large hetero-
geneity of the structure of arterial walls at different sites
constitutes an important limitation of PWV regional
measurement [45]. Furthermore, this convenient approach
to analyse PWV on an artery segment avoids coarse
approximations of the distance between the test points,
constituting an important advance in PWV assessment. In
fact, the carotid–femoral PWV assessment implies the
measurement of the distance between carotid and femoral
sites over the body surface. The accuracy of this mea-
surement is markedly influenced by either the distance
determination protocols or the presence of abdominal
obesity [27]. In fact, the expert consensus document in
arterial stiffness states that the PWV increases from 4 to
5 m s-1 in the ascending aorta, 5 to 6 m s-1 in the
abdominal aorta and 8 to 9 m s-1 in the iliac and femoral
arteries as the result from different studies [27]. A local
PWV measurement technique is hence preferred [27].
Murgo et al. in 1980, measured the PWV in 18 patients
by the catheterization in the ascending aorta and obtaining
an average over all patients of 6.68 m s-1 [25]. In 1985, a






PWV (m s-1) Devices References
Healthy 15 33 ± 3 8.9 ± 0.3 Pulse transducer probe
(Siemens Elema AB)
synchronism with ECG
Isnard et al. [33]
Hypertensive subjects 16 38 ± 3 11.8 ± 0.5
Healthy 418 46 ± 12 0.07 9 SP ?
0.09 9 age - 4.3
TY-360 pressure
transducer (Fukuda Co.)
Asmar et al. [34]
Normotensive subjects 124 45 ± 13 8.5 ± 1.5 Doppler unit (SEGA-
M842, Oregon, USA)
synchronism with ECG
Asmar et al. [35]
Untreated hypertensive patients 224 48 ± 11 11.8 ± 2.7
Treated hypertension patients 164 59 ± 11 10.1 ± 2.6
Hypertensive without
atherosclerosis
530 57 ± 13 12.4 ± 2.6 Complior Blacher et al. [36]
Hypertensive with atherosclerosis 180 67 ± 12 14.9 ± 4.0
Hypertensive without vascular
disease
196 57 ± 13 12.4 ± 2.7 Complior Bortolotto et al. [37]
Hypertensive with vascular disease 40 62 ± 13 14.3 ± 4.0
Subjects[70 years 141 87.1 ± 6.6 14.15 ± 3.11 Complior Meaume et al. [38]
Hypertensive patients 1980 50 ± 13 11.5 ± 63.4 Pulse transducer probes
(electronics for
medicine)
Laurent et al. [39]
Hypertensive without CV events 948 50 ± 12 11.4 ± 3.1 Pulse transducer probes
(electronics for
medicine)
Boutouyrie et al. [40]
Hypertensive with CV events 97 56 ± 13 12.8 ± 3.2
Female 800 53.5 10.8 ± 3.2 Two piezoelectric
pressure transducers
(Hellige GmbH)
Willum-Hansen et al. [41]
Male 878 54.3 11.8 ± 3.6
Female 1127 37 7.4 Complior,
SphygmoCor,
PulsePen
Vermeersch et al. [42]
Male 1080 39 8.2
Smoker 444 43 8.0
No smoker 2207 38 7.8
General population
(52 % hypertensive,
11 % diabetic, 17 % smokers)
2200 46.33 ± 13.77 10.05 ± 2.03 Complior Maldonado et al. [43]
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smaller set of nine patients yielded a measured of
4.4 ± 0.4 m s-1 for the aortic root PWV, also during the
catheterization [46].
The relationship between carotid–femoral and aortic
PWV was studied in 107 patients [47]. The velocities were
measured simultaneously during cardiac catheterization
and proved the higher values obtained in carotid–femoral
velocity (10.65 ± 2.29 m s-1) comparing to aortic veloc-
ity (8.78 ± 2.24 m s-1) [47].
Using an ultrasound (US) records, in 21 adults, the local
PWV was measured in the left common carotid artery and
values in range of 4–9 m s-1 were obtained [48], and it
was verified that the velocity is increasing with age. In
2008, an experimental method, based on US data with
higher frame rate, for the local determination of PWV in
the carotid artery obtained values for PWV of 3–4 m s-1,
however this study was only performed with one healthy
subject with 36 years [49].
Another technique, using magnetic resonance, allows
direct imaging of the thoracic and abdominal aorta. The
PWV can be determined by measuring the pulse wave at
two points in the vasculature and by estimating the path
length of the pulse wave. The mean PWV obtained with
this method in patients with diabetes mellitus, was
5.65 ± 0.75 m s-1 [26]. Table 2 summarized the main
characteristics of the studies dedicated for local PWV.
3 Devices
One of the major objectives of a CVD detection pro-
gramme should be to identify the persons who have
asymptomatic arterial disease in order to slow the pro-
gression of atherosclerotic disease and in particular to
reduce the risk of clinical manifestations. The revolution in
technology has a clear influence in the decision making of
CV patients diagnostics, and can be applied in the early
disease detection in asymptomatic patients. A large number
of devices, to measure arterial stiffness are currently
commercially available. The non-invasive measurement of
arterial stiffness is usually accomplished by a set of devices
that measure PWV and that provide capability to perform
pulse pressure waveform analysis. The most common
technique to non-invasively assess PWV is based on the
acquisition of pulse waves generated by the systolic ejec-
tion at two distinct locations, separated by a distance d, by
determining the time delay, or PTT, due to the pulse wave
propagation along the arterial tree. The PWV parameter is
then simply calculated as the linear ratio between d and the
PTT [50].
Many different pulse waveforms have been used to
assess PWV, such as pressure wave, distension wave or
flow wave. In previous studies, the comparison between
pressure and distension waveforms had shown that, these
waves can be used interchangeably for many analyses due
to their similar wave contour. The results of a number of
studies have concluded that the distension waves are
slightly less peaked than the pressure ones [51].
Some of the described equipment is able to determine
regional PWV and others which are able to determine the
local PWV measurement and are summarized in Table 2.
3.1 Currently Devices
In order, to non-invasively assess the CV system several
techniques have been developed. Some devices are rou-
tinely used in diagnostic work-up programmes in the clinic
environment but they have rarely been used in the popu-
lation as image screening tools such as magnetic resonance
imaging (MRI) or ultrasonic sensors. However, these are















Murgo et al. [25]




Latham et al. [46]
Cardiac patients 107 60.49 ± 8.31 8.78 ± 2.24
Aortic velocity
Catheter (6 Fr right
Judkins catheter)
Podolec et al. [47]





Rabben et al. [48]
Healthy 16 55 ± 7 5.65 ± 0.75 MRI (Gyroscan ACS/
NT15, Philips, Best,
The Netherlands)
Van der Meer et al. [26]
Type 2 diabetes mellitus 14 55 ± 8 6.83 ± 1.60
Aortic velocity
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usually seen as a costly technique and difficult to operate.
More recently, new techniques have become available to
detect new and several hemodynamic parameters. Pressure
sensors, such as the tonometer, is considered the gold
standard method for measuring PWV, but some operating
skill is required to use this method which may influence the
measurement. As a result, the tonometry technique of PWV
assessment is usually used in research and clinical settings
by well trained operators, but not widespread use in clinical
or in ambulatory environments (Table 3).
3.1.1 PulsePen
The PulsePen (DiaTecne, Milan, Italy) is composed of one
tonometer and integrated an electrocardiogram (ECG) unit.
The delay between pulse waves is determined by appla-
nation tonometry obtains at the carotid and femoral syn-
chronized with the ECG R peak and the foot of the wave
determined [53].
3.1.2 Complior
The Complior (Colson, France) uses two dedicated
piezoelectric pressure mechanotransducers directly applied
to the skin in a simultaneous measurement of pressure
pulses. The Complior was validated through a range of
epidemiological studies that demonstrate the predictive
value of PWV in CVDs. One probe is positioned at the
common carotid artery, the central detection site, whereas
the other probe is placed at the femoral artery site. How-
ever it is possible to determine the PWV in several path-
ways like carotid–femoral, carotid–brachial or femoral–
dorsalis pedis without the need of ECG recordings [54].
3.1.3 SphygmoCor
SphygmoCor (AtCor Medical, Sydney, Australia) ana-
lyzes the pulse wave of the carotid and femoral arteries,
estimating the delay with respect to the ECG wave and
calculating the PWV. SphygmoCor offers the possibility of
carotid–femoral PWV measurements in two steps. The first
step is used to simultaneously record carotid pulse wave
and ECG, while the second step is the recording of femoral
pulse wave and ECG. ECG recording during measurements
is necessary for synchronization of carotid and femoral
pulse wave times [54].
In the previously described techniques, PulsePen,
Complior and SphygmoCor, the wave pathway is measured
on the body surface. Distance measurements are taken with
a measuring tape from the sternal notch to the carotid and
femoral arteries at the sensor location. In fact, this mea-
sured distance is an estimation of the true distance travelled
by the front wave and largely depends on body habitus
[54], thus introducing a significant systematic error in the
PWV estimation.
3.1.4 Arteriograph
Arteriograph (TensioMed, Budapest, Hungary) does not
measure propagation time from carotid to femoral wave-
form recordings or the distance between carotid and
femoral arterial recording sites. The main principle of
PWV estimation behind the Arteriograph device is to
record oscillometric pressure curves based on plethys-
mography and register pulsatile pressure changes in an
artery on the upper arm [54]. Since fluctuations in pulsatile
pressure in the artery beneath the inflated pressure cuff
induce periodic pressure changes in the inflated cuff, the
oscillometric method measures these periodic pressure
changes (oscillations) as an indirect measure for the pul-
satile pressure changes in the artery beneath [55]. The
pressure fluctuations in the brachial artery detected by the
cuff are analyzed and the difference in time between the
beginning of the first wave and the beginning of the second
(reflected wave) is related to the distance from the jugulum
to the symphysis, resulting in the PWV. The software of
the Arteriograph decomposes the early, late systolic and
diastolic waves and also determines the onset and the peaks
of the waves [55]. This device uses an arm cuff like a
sphygmomanometer, systolic and diastolic BPs are used for
calibrate the system.
3.1.5 Photoplethysmography
Photoplethysmography is another non-invasive method for
the detection of pressure waves propagated around the
human body. The advantages of this method are: move-
ment artefacts reduction [infrared (IR) probes lightly held
against the skin without perturbing the physiological sys-
tem], IR can then explore deep arteries according to the
wavelength and to the distance between the light source
and the detector. This latter characteristic is very
Table 3 Devices and methods used to determine arterial stiffness
Methods Measurements Devices




Local PWV Magnetic resonance image
Ultrasound
Invasive Local PWV Angiography
Adapted from [52]
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interesting for assessing PWV in overweight populations.
However this technique can only be applied to peripheral
sites of the body. Pressure wave of blood undergoes
changes in arterial tree, so that the waves obtained by this
method don’t give reliable information from one central
system.
The measurements of PWV in overweight and obese
subjects may be of major interest in assessing CV risk.
However, obesity is a well known factor of technical
operator bias when assessing PWV. The image techniques
are a commercial solution to acquire signals when the fatty
deposit prevents the acquisition by other methods.
3.1.6 Ultrasound
The US technique allows the determination of the PWV by
estimating the time delay between the diameter waveforms
recorded simultaneously at two close positions along the
vessels. The PWV is determined by the ratio of the tem-
poral and the longitudinal diameter gradients. Alternatively
the US may analyze the carotid and femoral waves
simultaneously or separately using ECG synchronization
[52]. These techniques depend on a reliable identification
of the foot of the diameter waveforms and a sufficiently
high sampling frequency. Another method from US mea-
surements estimates local PWV as the ratio between
change in flow and change in cross-sectional area during a
cardiac cycle [48].
3.1.7 Magnetic Resonance Imaging
PWV measured by MRI allows the accurate assessment of
the blood flow velocity with an enough temporal and
spatial resolution to study the propagation of the aortic
systolic flow wave [56]. MRI is a non-invasive technique
that allows direct imaging of the thoracic and abdominal
aorta without the use of geometric assumptions. The
accurate and direct measurement of the path length of pulse
waves in the proximal and distal aorta, even in the presence
of a tortuous vessel, is a major advantage over other
techniques [26].
The MRI allows the assessment of PWV, or other aortic
vascular parameters (aortic distensibility, aortic compli-
ance, aortic elastic modulus, and aortic stiffness index)
[26]. Aortic PWV was calculated as Dx/Dt, where Dx is the
aortic path length between the two imaging levels and Dt is
the time delay between the arrival of the foot of the flow
pulse wave at these levels [26, 57]. To extract ascending
and descending aorta flow curves, aortic lumen contours
are segmented. The intersection of the tangent line to the
upstroke and the baseline were considered as the arrival
time of the pulse wave [56].
3.1.8 Invasive Measurement
The best method for measuring PWV in aortic vessel is the
threaded catheterization from a peripheral artery, during an
angiography procedure. However, the invasive nature has
several disadvantages and this method cannot be justified
except during a cardiac diagnostic or vascular procedure
[58].
3.2 Non-commercial Devices: Novel Solutions
Prototypes
The clinical application of novel non-invasive instrumen-
tation can overcome practical and technical limitations
inherent to the currently used methods such as arterial
applanation tonometry, US and plethysmography that
require physical contact of the probe with the patient and
compress the artery throughout an entire cardiac cycle.
These measurement techniques are affected by the Ber-
noulli effect that distorts the shape of the pulse curve itself
[59, 60].
In tonometry, the probe needs to be placed over the
widest pulsation area, and requires support from solid
structures like the bone. For this reason, it is difficult to
make valid measurements with applanation tonometry over
the carotid artery, since they are usually involved in soft
tissues [61]. Due to the contact nature, the exact position-
ing of the sensors is crucial for the correct measurement of
PWV, and in consequence the quality of the recordings is
strongly dependent of the operator. Several efforts have
been done in the last decade to develop novel instrumen-
tation which provides non-contact measurements. The
following prototypes describe several systems based opti-
cal techniques that allow the monitoring of the PWV and
other vital signals without contact with patient, which
represent promising techniques for PWV measurement
without distortion.
Meigas et al. presented an optical device based on self-
mixing interferometry coupled with fiber optics to measure
the carotid artery displacement. Along the optical sensor,
an ECG was performed in order to determine pulse time
delay [62]. Jukka et al. developed a self-mixing interfer-
ometry prototype applied to CV pulse measurements. The
technique is used for pulse pressure waveform detection
over the radial artery [63]. Scalise et al. proposed an optical
procedure, with two optical head based Doppler vibrometer
for measurements at long distances, suitable for monitoring
the cardiac activity [64]. Mirko et al. developed a system
based optical vibrocardiography for measure the regional
PWV at the carotid and femoral site, with ECG signal for
the synchronism [65]. Pereira et al. tested probes for local
PWV measurement based coherent and non-coherent light,
with two photodetectors placed 20 mm apart [66, 67].
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The measurements of PWV in overweight and obese
subjects may be of major interest in assessing CV risk.
However, obesity is a well known factor which introduces
difficulties in the assessment of arterial pulse wave for
contact nature systems, the fatty deposits turns the signals
acquisition a hard task to accomplish. The optical solu-
tions, using light wavelengths that allows tissue penetra-
tion, captures the pulse waveform deep of the skin [68].
Yanlu Li et al. suggested a system with two laser Doppler
vibrometry as a potential technique to measure the local
carotid PWV in two locations along the common carotid
artery from skin vibrations [69]. Recently, Adriaan
Campo et al. presented an instrument with a double laser
Doppler vibrometer to assess the local PWV at the carotid
site [70].
3.3 Comparison of Currently Methods
The current methods used to measurement the PWV can be
divided in three main groups: imaging, non-imaging and
optical methods. Each method has advantages and disad-
vantages (summarized in Table 4), and for this reason the
PWV estimation remains a challenge for the engineers and
clinicians.
The imaging methods, such US and MRI, take advan-
tage of the pulse waves path length direct measurement and
avoid the error induced by the coarse estimation of distance
between the pulse pressure waveforms. However, these
methods are very expensive and are not used in clinical
routines. Non-imaging methods based in the pressure
mechanotransducers are more affordable and extensively
studied and validated in different populations, although,
this method have problems on obese people signal acqui-
sition, and have errors associated with distance estimation
between the waveforms and originated with pressure
exerted at the measurement site. The optical methods
emerged to overcome the limitations of the previous
methods. The optical solutions are low-cost, allows a non-
contact measurement and the IR light allows the signal
detection in obese people due to its penetration capability.
These novel solutions are at an early stage of validation and
nonetheless show very encouraging results.
4 Conclusions
Although the arterial stiffness is accepted as one of the
most useful parameter for assessment of the CV system, the
discussion about its precise indirect measurement is open.
The regional PWV was extensively studied in different
groups of patients with distinct pathologies in order to
establish the correlation between the PWV measurement
with disease condition and the characteristics of popula-
tion. However, considering the heterogeneous process of
arterial stiffness, a diagnosis tool for measure the local
stiffness of the arterial wall represents an important
advance for an early and precise assessment of arterial
condition.
Methods of PWV measurements have been refined since
the early attempts at analysis, and have several relatively
novel non-invasive methods for measuring the arterial
pulse wave. Great importance has been done to novel
solutions based non-contact techniques that allow over-
coming the main limitations of current commercial devi-
ces. The optical sensors are an attractive instrumental
solution in this kind of time assessment applications due to
their truly non-contact nature that allows the measurement
of local PWV in the carotid artery. The use of IR light,
wavelengths which penetrates in the tissues, allows the
arterial pulse wave acquisition in obesity cases. Moreover,
its simple architecture, its time resolution and the lower
production costs makes the use of optical prototypes very
interesting and competitive. Good results were obtained in
the preliminary tests of the developed optical prototypes.
However, it is necessary further clinical researches with
pathological populations in order to study the correlations
with the local PWV. Future studies should provide the
robust evidence of local PWV importance as a tool to
determine the arterial stiffness in early stages.
An ideal method for arterial stiffness assessment would
be able to measure the parameter directly, without any
intermediate model or transfer function, to be an inde-
pendent predictor for CV events, providing accurate
information about the health condition of the patient, to be
easy to use in daily clinical practice; allow a non-invasive
and non-contact measurement and, to be validated in
Table 4 Advantages and disadvantages of methods to PWV measurement
Methods Advantages Disadvantages
Imaging Direct measurement of the path length Expensive technology
Non-imaging More affordable (less expensive) and validated
technology
Error associated with distance estimation, distortion in the
acquisition signal, problems to access the signal in obese people,
only allows a regional assessment
Optical Low cost technology, measurement without
contact, capability to acquire the signal in obese
persons
Early stage of validation
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numerous studies with different groups of patients pro-
viding reference values that are accepted by the clinical
community. The optical methods represent the non-inva-
sive closest solution to this objective, allowing the mea-
surement of PWV without contact, preserving the signal
without interfering, and assessing the local PWV which is
the earlier biomarker for arterial stiffness evaluation. The
combination of this method with machine learning tech-
niques would create an operator free system, thereby
decreasing the error factor in signal detection and simpli-
fying the acquisition.
With the development of new techniques that is become
simpler, less expensive and more efficient, it is expected
that the measurement of arterial stiffness will become an
important part of clinical routine.
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